<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="https://www.vetsurgeon.org/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>pyloric carcinoma</title><link>https://www.vetsurgeon.org/f/clinical-questions/9332/pyloric-carcinoma</link><description> 10 yo cocker with a carcinoma in ploric muscularis externa but thickend lymphatics/fat extending into the duodenum. being treated paliatively and I do not feel radical resection would be fair as this may not be the primary. Any chemo sugestions or any</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator><item><title>Re: pyloric carcinoma</title><link>https://www.vetsurgeon.org/thread/45323?ContentTypeID=1</link><pubDate>Sat, 17 Sep 2011 08:55:20 GMT</pubDate><guid isPermaLink="false">146601cc-3922-4be7-9974-7e1d4e45a66b:ad803b42-ab3e-4fd4-986a-5eaae0b594be</guid><dc:creator>Richard Fox</dc:creator><description>&lt;p&gt;&amp;quot;Masivet is of course primarily designed for mast cell tumours&amp;nbsp;but there 
is evidence as I understand it&amp;nbsp;to suggest that as inflammation plays a 
big part in metastatic spread and mast cells play a big part in 
inflammation masitinib may limit metastases or at least the impact of 
them and therefore has a role in treatment of other tumours, by allowing
 unaffected cells to &amp;#39;fight back&amp;#39;&amp;nbsp;and sensitise tumour cells to other 
forms of chemotherapy.&amp;quot;&lt;/p&gt;
&lt;p&gt;I was aware that multistep mutagenesis was the main method that tumour cells acquire an in invasive and or metastatic phenotype - many malignant neoplasms are not associated with inflammation. I have not heard of mast cells being directly involved in carcinoma metastastasis Martin - have you a reference for this as I would be interested?&lt;/p&gt;
&lt;p&gt;I am afraid I would prepare the owners for the worst myself?&lt;/p&gt;&lt;div style="clear:both;"&gt;&lt;/div&gt;</description></item><item><title>Re: pyloric carcinoma</title><link>https://www.vetsurgeon.org/thread/45221?ContentTypeID=1</link><pubDate>Thu, 15 Sep 2011 18:27:39 GMT</pubDate><guid isPermaLink="false">146601cc-3922-4be7-9974-7e1d4e45a66b:77291ab3-4cf5-48e4-b768-7efb235f87b3</guid><dc:creator>Martin Atkinson</dc:creator><description>&lt;p&gt;Masivet is of course primarily designed for mast cell tumours&amp;nbsp;but there is evidence as I understand it&amp;nbsp;to suggest that as inflammation plays a big part in metastatic spread and mast cells play a big part in inflammation masitinib may limit metastases or at least the impact of them and therefore has a role in treatment of other tumours, by allowing unaffected cells to &amp;#39;fight back&amp;#39;&amp;nbsp;and sensitise tumour cells to other forms of chemotherapy. It can&amp;#39;t be any more harmful than not doing anything&amp;nbsp;as long as the client is aware that there are side effects. So far as I&amp;nbsp; am aware there is not much else that is worth trying in the chemo field.&lt;/p&gt;&lt;div style="clear:both;"&gt;&lt;/div&gt;</description></item><item><title>Re: pyloric carcinoma</title><link>https://www.vetsurgeon.org/thread/45195?ContentTypeID=1</link><pubDate>Thu, 15 Sep 2011 16:40:33 GMT</pubDate><guid isPermaLink="false">146601cc-3922-4be7-9974-7e1d4e45a66b:fda87fb7-b2cb-4004-bae5-2287bf00400b</guid><dc:creator>Mark Rowland</dc:creator><description>&lt;p&gt;Sounds like a phonecall to the VRCC is in order &lt;img src="https://www.vetsurgeon.org/emoticons/v2/Light.png" alt="Idea" /&gt;&lt;/p&gt;&lt;div style="clear:both;"&gt;&lt;/div&gt;</description></item></channel></rss>